Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Krzysztof Palczewski
University of California Irvine, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Polgenix
Salary not from the awardee Institution
The research focuses on identifying effective and safe combinations of therapeutic agents targeting GPCRs, which is one of Polgenix’s main business interests.
Use of systems pharmacology to prevent rod and cone photoreceptor degeneration
NARRATIVE Degeneration of photoreceptor cells and the retinal pigment epithelium is the underlying cause of a large number of progressive retinal diseases, of which many have only minimally effective or no treatment options. Thus, additional therapeutic approaches are urgently needed to reduce vision loss associated with these disorders. The long-term objective of this proposal is to provide mechanism-based therapeutic interventions that successfully combat degenerative retinal diseases. Systems pharmacology holds promise as a safe and highly efficacious therapeutic approach for such disorders. Using this novel approach, we aim to identify therapeutic agents that slow or halt the development and progression of retinopathies in animal models as a prelude to their clinical evaluation in humans.
Filed on June 12, 2019.
Tell us what you know about Krzysztof Palczewski's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Krzysztof Palczewski filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | $150,000 - $199,999 |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | $150,000 - $199,999 |
| Krzysztof Palczewski | Case Western Reserve University | Conflict of Interest | Polgenix | $80,000 - $99,999 |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | Value cannot be readily determined |
| Krzysztof Palczewski | Case Western Reserve University | Conflict of Interest | Polgenix | Value cannot be readily determined |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | Value cannot be readily determined |
| Krzysztof Palczewski | Case Western Reserve University | Conflict of Interest | Polgenix | Value cannot be readily determined |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.